Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-30 @ 7:55 PM
Study NCT ID:
NCT04311957
Status:
UNKNOWN
Last Update Posted:
2020-08-03
First Post:
2020-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Sponsor:
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-03-15
First Submit QC Date:
None
Study First Post Date:
2020-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-30
Last Update Post Date:
2020-08-03
Last Update Post Date Type:
ACTUAL